Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Phytother Res. 2018 Jan 29;32(4):750–754. doi: 10.1002/ptr.6016

Figure 2. Pharmacogenomic analyses.

Figure 2

(A) Chemical structure of neovestitol. (B) Canonic map representing the effect of neovestitol treatment (IC20) in HeLa cells, causing down-regulation of genes enrolled with the PGE2 pathways in cancer (fold = −3.12). The thermometer next to the component indicates the magnitude of the modulation of gene expression (structure circulated in red; MetaCore, Thomson Reuters).